Human brain trauma severity is associated with lectin complement pathway activation.
MBL-associated serine proteases
Traumatic brain injury
complement system
lectin complement pathway
neuroinflammation
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
10
2
2018
medline:
28
4
2020
entrez:
10
2
2018
Statut:
ppublish
Résumé
We explored the involvement of the lectin pathway of complement in post-traumatic brain injury (TBI) pathophysiology in humans. Brain samples were obtained from 28 patients who had undergone therapeutic contusion removal, within 12 h (early) or from >12 h until five days (late) from injury, and from five non-TBI patients. Imaging analysis indicated that lectin pathway initiator molecules (MBL, ficolin-1, ficolin-2 and ficolin-3), the key enzymes MASP-2 and MASP-3, and the downstream complement components (C3 fragments and TCC) were present inside and outside brain vessels in all contusions. Only ficolin-1 was found in the parenchyma of non-TBI tissues. Immunoassays in brain homogenates showed that MBL, ficolin-2 and ficolin-3 increased in TBI compared to non-TBI (2.0, 2.2 and 6.0-times) samples. MASP-2 increased with subarachnoid hemorrhage and abnormal pupil reactivity, two indicators of structural and functional damage. C3 fragments and TCC increased, respectively, by 3.5 - and 4.0-fold in TBI compared to non-TBI tissue and significantly correlated with MBL, ficolin-2, ficolin-3, MASP-2 and MASP-3 levels in the homogenates. In conclusion, we show for the first time the direct presence of lectin pathway components in human cerebral contusions and their association with injury severity, suggesting a central role for the lectin pathway in the post-traumatic pathophysiology of human TBI.
Identifiants
pubmed: 29425056
doi: 10.1177/0271678X18758881
pmc: PMC6501516
doi:
Substances chimiques
Complement C3
0
Lectins
0
Mannose-Binding Lectin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
794-807Références
Diabetes. 2001 Jan;50(1):77-82
pubmed: 11147798
J Neurotrauma. 2001 Aug;18(8):773-81
pubmed: 11526983
J Neurotrauma. 2001 Dec;18(12):1295-311
pubmed: 11780861
Blood. 2003 Feb 1;101(3):1071-9
pubmed: 12393727
Int Immunol. 2003 Jan;15(1):109-17
pubmed: 12502731
J Immunol. 1992 Aug 15;149(4):1381-7
pubmed: 1386864
Exp Neurol. 2006 Jun;199(2):454-64
pubmed: 16545803
BMC Neurosci. 2006 Jul 14;7:55
pubmed: 16842619
Lancet Neurol. 2007 Jan;6(1):29-38
pubmed: 17166799
Trends Immunol. 2007 Apr;28(4):184-92
pubmed: 17336159
J Cereb Blood Flow Metab. 2007 Dec;27(12):1954-64
pubmed: 17457366
J Neuroinflammation. 2007 May 02;4:13
pubmed: 17474994
BMJ. 2008 Feb 23;336(7641):425-9
pubmed: 18270239
Lancet Neurol. 2008 Aug;7(8):728-41
pubmed: 18635021
PLoS Med. 2008 Aug 5;5(8):e165; discussion e165
pubmed: 18684008
Crit Care Med. 2009 Feb;37(2):659-65
pubmed: 19114897
J Neuroinflammation. 2009 Jan 08;6:2
pubmed: 19133139
J Neuropathol Exp Neurol. 2009 Sep;68(9):964-71
pubmed: 19680147
Immunobiology. 2010;215(1):1-11
pubmed: 19783065
Ann Neurol. 2009 Sep;66(3):332-42
pubmed: 19798727
Immunobiology. 2010 Nov;215(11):921-31
pubmed: 19939495
PLoS One. 2010 Feb 03;5(2):e8433
pubmed: 20140243
Lancet Neurol. 2010 May;9(5):543-54
pubmed: 20398861
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
Intensive Care Med. 2011 Feb;37(2):302-9
pubmed: 21072498
Int J Biochem Cell Biol. 2011 May;43(5):705-12
pubmed: 21315829
J Immunol. 2011 Oct 1;187(7):3751-8
pubmed: 21865552
Shock. 2012 Apr;37(4):348-54
pubmed: 22258234
J Neuroinflammation. 2012 Jun 21;9:137
pubmed: 22721265
Circulation. 2012 Sep 18;126(12):1484-94
pubmed: 22879370
Nat Rev Neurol. 2013 Apr;9(4):231-6
pubmed: 23443846
Scand J Immunol. 1985 Aug;22(2):197-202
pubmed: 2412280
Neurology. 2014 Jan 14;82(2):126-34
pubmed: 24336142
J Immunol. 2014 May 1;192(9):4352-60
pubmed: 24683193
Crit Care Med. 2014 Aug;42(8):1910-8
pubmed: 24810526
Front Cell Neurosci. 2014 Nov 07;8:380
pubmed: 25426028
Clin Chim Acta. 2015 Dec 7;451(Pt B):111-6
pubmed: 26525964
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14319-24
pubmed: 26578778
J Neuroinflammation. 2015 Dec 01;12:226
pubmed: 26627059
J Neuroinflammation. 2016 Jan 20;13:16
pubmed: 26792363
JAMA Neurol. 2016 May 1;73(5):542-50
pubmed: 27019039
J Comp Pathol. 2016 May;154(4):323-8
pubmed: 27156898
J Cereb Blood Flow Metab. 2017 Mar;37(3):938-950
pubmed: 27165013
Sci Rep. 2016 Aug 18;6:31877
pubmed: 27535802
J Neuroinflammation. 2016 Aug 30;13(1):213
pubmed: 27577570
Immunol Rev. 2016 Nov;274(1):98-111
pubmed: 27782318
Immunol Rev. 2016 Nov;274(1):74-97
pubmed: 27782323
Stroke. 2016 Dec;47(12):3067-3073
pubmed: 27811336
Nat Rev Neurol. 2017 Mar;13(3):171-191
pubmed: 28186177
Front Immunol. 2017 Mar 16;8:288
pubmed: 28360913
J Neurotrauma. 2017 Sep;34(17):2560-2566
pubmed: 28482760
Anaesthesist. 1987 Jun;36(6):301-5
pubmed: 3498378
Scand J Immunol. 1985 Aug;22(2):183-95
pubmed: 4035298
J Neuroimmunol. 1997 Mar;73(1-2):63-9
pubmed: 9058760
J Neurotrauma. 1998 Oct;15(10):731-69
pubmed: 9814632